logo

Anavex Life Sciences Corp. (AVXL)



Trade AVXL now with
  Date
  Headline
7/3/2018 7:01:27 AM Anavex Life Sciences Gets Approval To Initiate Phase 2b/3 Clinical Trial Of ANAVEX®2-73 For Early Alzheimer’s Disease
5/10/2018 7:16:17 AM Anavex Life Sciences Q2 Net Loss Widens To $4.8 Mln Or $0.11/shr From $1.5 Mln Or $0.04/shr Last Year
4/17/2018 7:08:11 AM Anavex Life Sciences To Initiate Phase 2 Study Of ANAVEX®2-73 In Parkinson’s Disease Dementia
3/5/2018 7:08:00 AM Anavex Life Sciences Appoints Stephan Toutain As SVP Of Operations And Claus Van Der Velden To Board
2/13/2018 2:16:57 PM Anavex Life Sciences Stock Price Target Cut To $5 From $14 At Maxim Group
2/7/2018 7:11:06 AM Anavex Life Sciences Q1 Net Loss $4.1 Mln Or $0.09/Shr Vs Net Loss $3.1 Mln Or $0.08/Shr Last Year
  
 
>